Dr. Sanjeev Goel, M.D.: Why the ApoB Test Matters More Than Your Cholesterol and What Your Doctor Isn’t Checking

Heart disease rarely appears overnight. In most cases, it develops quietly over decades, long before symptoms show up. Many people assume their risk is low if their yearly blood work shows “normal” cholesterol numbers. Yet cardiologists regularly see patients suffer heart attacks despite having lab results that looked acceptable just months earlier.

The scale of the problem is enormous. Cardiovascular diseases cause about 19.8 million deaths globally each year, representing roughly 32% of all deaths worldwide. Despite being largely preventable, cardiovascular disease (CVD) causes more than 20.5 million deaths every year. Despite this, many people still rely solely on routine cholesterol panels to understand their risk.

What makes this especially concerning is that an estimated 80% of cardiovascular disease, including heart disease and stroke, is preventable. Yet many people only begin thinking seriously about their cardiovascular health after symptoms appear.

Part of the challenge is that routine blood tests do not always capture the deeper signals of cardiovascular risk. Traditional lipid panels provide useful information, but they don’t always tell the full story. As research evolves, more physicians are beginning to look beyond standard cholesterol markers to identify risks earlier and prevent disease before it develops.

In clinical practice, this gap can become clear. After more than two decades in family medicine, Dr. Sanjeev Goel, M.D., Founder and CEO of Peak Human, says he has seen many patients whose routine lab results appeared acceptable, yet they later developed cardiovascular disease.

For him, the search for better answers also became personal. His father-in-law died suddenly of a heart attack at age 60. The loss raised a difficult question: if someone appears healthy and routine tests look normal, what warning signs might be hiding beneath the surface?

One answer may lie in a marker that is still rarely included in standard testing: the ApoB test.

Why Standard Cholesterol Tests Can Miss Risk

Traditional cholesterol panels measure the amount of cholesterol circulating in the blood, but they do not directly measure how many particles are carrying it. This distinction matters because plaque formation in the arteries is driven by the number of lipoprotein particles that can enter the artery wall.

Two individuals can have identical LDL cholesterol levels but very different particle counts. One person may have fewer, larger particles that carry more cholesterol, while another may have many smaller particles circulating in the bloodstream. On a standard lipid panel, these two people can appear similar even though their cardiovascular risk may be quite different.

Apolipoprotein B, or ApoB, offers a clearer view. The protein sits on the surface of every potentially plaque-forming particle, including LDL, VLDL, and lipoprotein(a). Because each particle contains exactly one ApoB protein, measuring ApoB provides a direct estimate of the total number of atherogenic particles circulating in the bloodstream.

Preventive physicians often consider ApoB levels below about 80 mg/dL to be optimal, while levels above 130 mg/dL may signal significantly higher risk. Despite its strong predictive value in research, ApoB testing is still not included in many routine screenings, even though physicians believe it is a better marker of cardiovascular risk than the traditional marker LDL.

Understanding Triglycerides Normal Range and Cardiovascular Health

Triglycerides are another marker that reflects overall metabolic health. They represent the amount of fat circulating in the bloodstream and are strongly influenced by diet, insulin sensitivity, and physical activity.

Most clinical guidelines define healthy triglyceride levels as below 150 mg/dL; however, many physicians who focus on prevention aim for lower values.

General reference points include:

• Below 150 mg/dL: within the standard healthy range
• Below 100 mg/dL: often considered metabolically favorable
• Around 70 mg/dL: commonly associated with strong metabolic health

Even when levels fall within the conventional range, higher values can sometimes signal early metabolic issues such as insulin resistance or chronic inflammation.

Elevated triglycerides are often linked to diets high in refined carbohydrates and added sugars, as well as sedentary lifestyle patterns. These same factors frequently appear alongside elevated ApoB levels.

How to Lower ApoB Through Lifestyle First

For people concerned about cardiovascular health, daily habits can have a measurable impact on lipid markers over time. While medications may be necessary in some cases, many prevention strategies begin with lifestyle changes that influence how the body produces and clears lipoproteins.

One of the most consistent findings in research is the role of diet quality. Diets rich in vegetables, legumes, whole grains, and other fiber-dense foods are associated with healthier lipid profiles. Fiber helps the body remove excess cholesterol and can support better metabolic function. For readers looking for a practical step, increasing fiber intake and reducing ultra-processed foods is often a useful place to start.

Physical activity is another key factor. Regular aerobic exercise helps the body process fats more efficiently and improves how lipoproteins are cleared from the bloodstream. Moderate-intensity endurance exercise, sometimes referred to as Zone 2 training, has been linked to improvements in fat metabolism and insulin sensitivity.

Eating patterns can also influence lipid markers. Some studies suggest that time-restricted eating, where meals are consumed within a consistent daily window, may help lower triglycerides and improve metabolic health. While not necessary for everyone, it can be one option people explore with their healthcare provider.

Tracking blood markers over time can also be helpful. Periodic follow-up tests, including the apolipoprotein B test, may show whether lifestyle changes are influencing lipid particle levels. Dr. Goel notes that looking at trends over time can provide more useful insight than a single lab result.

The broader takeaway is that improvements in metabolic health often show up across several markers at once. Regular exercise, balanced nutrition, and stable eating patterns can contribute to healthier normal triglyceride levels, better insulin sensitivity, and more favorable lipid measurements over time.

When to Consider Advanced Interventions Beyond Lifestyle

Lifestyle improvements such as exercise and avoiding tobacco smoke are often the first step in reducing cardiovascular risk, but they do not always bring every marker into an optimal range. Genetics, long-standing metabolic conditions, and other factors can influence how the body regulates lipids.

Some individuals, for example, inherit lipid disorders that keep ApoB levels elevated despite consistent diet and exercise. In those situations, physicians may discuss medications such as statins and PCSK9 inhibitors as part of a broader treatment strategy. These therapies work in different ways to reduce the number of circulating lipoprotein particles.

In rare and more severe lipid disorders, additional treatments such as plasmapheresis, which filters certain lipoproteins from the blood, may be considered under specialist care.

It is also important to remember that lipid markers are only one component of cardiovascular risk. Elevated ApoB frequently appears alongside other conditions such as metabolic syndrome, insulin resistance, or chronic inflammation. In fact, underlying inflammation or “stickiness” of platelets to damaged vessel walls seems to be an important factor in the development of arterial plaque.  Several new blood biomarkers measure these inflammatory factors in a test called Prevencio.

Because of this, many clinicians evaluate cardiovascular health from multiple angles rather than relying on a single number. Alongside standard cholesterol markers and ApoB, doctors may also consider factors such as lipoprotein(a), inflammatory markers like hs-CRP, or imaging tests such as coronary artery calcium scans.

The key takeaway is that an assessment of your cardiovascular risk is dependent on more than the standard lipid marker LDL. It rarely depends on a single measurement. A combination of metabolic health, lifestyle habits, and genetic factors will shape your overall disease risk.